Mendoza DS, Zavala MA, López TNL, Rodríguez ZJJ, Ramírez LJ

Language: Spanish
References: 16
Page: 14-17
PDF size: 122.65 Kb.

ABSTRACT

A high number of neonates suffer respiratory distress. This pathology is the principal cause of the admission to the Neonatal Intensive Care Units.
The aim of our study was determine the oxygen index in neonates admitted in our Hospital, from May 1, 1997 to April 31, 1998. The study design was cross-sectional. We studied 25 neonates with diagnosis of Respiratory Distress Syndrome (RDS), Meconium Aspiration Syndrome (MAS), and Patency of the Ductus Arteriosus (PDA). We calculated PAO₂, Da-vO₂, Fick and Kirby Index, DA-aO₂ and Qs/Qt to each patient.
In Respiratory Distress Syndrome were anormal DA-aO₂, Kirby and Fick Index, Da-vO₂, Qs/Qt. In PDA were anormal DA-aO₂, Kirby and Fick Index, Qs/Qt. Finally, in MAS we observed sligthy altered DA-aO₂, Kirby and Fick Index, Da-vO₂, Qs/Qt.
We concluded the Oxygen Index are mainly altered in Respiratory Distress Syndrome, and in second tern Meconium Aspiration Syndrome and Patency of the Ductus Arteriosus.

REFERENCES

1. Hayden WR: Respiratory monitoring. En: Rogers MC: Textbook of Pediatrics Intensive Care. USA, Williams & Wilkins, 1992: 204-30.

2. Harris T, Wood B. Physiologic principles. En: Goldsmith J, Karotkin E: Assisted ventilation of the neonate. USA, WB Saunders Company, 1996: 57-62.

3. William E, Alan H. Principles of management of respiratory problems. En: Avery GB: Neonatology: Pathophysiology and management of the newborn. 4th edition. USA, JB Lippincott Co, 1994: 478-504.

4. Boynton BR, Hammond MD. Pulmonary gas exchange: Basic principles and the effects of mechanical ventilation. En: Boyntonn BR: New therapies for neonatal respiratory failure: A physiological approach. USA, Cambridge University Press, 1994: 117-128, 174-176.

5. Lozano EMA, Aldaco OJ, Castillo EM. Cateterismo arterial periférico. Rev Iberolat C Int 1997; 4: 123-6.

6. Morales SM, Guzmán RLA. Síndrome de aspiración de meconio. Rev Perinatol 1995; 10: 2-7.

7. Garduño EA. La insuficiencia respiratoria grave en el niño. Acta Pediatr Mex 1987; 8: 52-63.

8. Yeh TF, Luken JA. Pharmacologic closure of patent ductus arteriosus. En: Neonatal therapeutics. USA, 2nd edition, Mosby Year Book 1991: 123-38.

9. Paulson TE. New concepts in the treatment of children with acute respiratory distress syndrome. J Pediatr 1995; 127: 163-75.

10. Charon A, Taeush W. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatrics 1989; 83: 348-54.

11. Caballero R, Clark RH, Wright JA. Outcome of respiratory failure: A case control study. Clin Pediatr Phil 1996; 35: 199-204.

12. Paulson TE, Spear RM, Peterson BM. New concepts in the treatment of children with acute respiratory distress syndrome. J Pediatr 1995; 127: 163-75.

13. Sarnaik AP, Meert KL. Predicting outcome in children with severe acute respiratory failure treated with high-frequency ventilation. Crit Care Med 1996; 24: 1396-1401.

14. Stock MC, Ryan ME. Oxigen consumption calculated from Fick equation has limited utility. Crit Care Med 1996; 24: 86-90.

15. Thrush DN. Spirometric versus Fick-derived oxygen consumption: Which method is better? Crit Care Med 1996; 24: 91-5.

16. Cassels D, Morse M. Effect of the patent ductus arteriosus on the pulmonary blood flow, blood volumes, heart rate, blood pressure, arterial blood gases and pH. Pediatrics 1950; 6: 557-72.